Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2026-01-26 | Feld Michael | EVP, CRO & Pres. Life Sciences | Sell | 75 | $202.73 | $15,204.75 | -0.5% | → |
| 2025-12-26 | Feld Michael | EVP, CRO & Pres. Life Sciences | Sell | 74 | $196.08 | $14,509.92 | -0.4% | → |
| 2025-12-17 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | Sell | 629 | $196.03 | $123,302.87 | -4.6% | → |
| 2025-12-01 | Feld Michael | EVP, CRO & Pres. Life Sciences | Sell | 75 | $193.36 | $14,502.00 | -0.5% | → |
| 2025-11-07 | SCOTT BERTRAM L | Director | Sell | 217 | $176.58 | $38,317.86 | -0.6% | → |
| 2025-10-27 | Feld Michael | EVP & President, Life Sciences | Sell | 57 | $186.01 | $10,602.57 | -0.7% | → |
| 2025-09-26 | Feld Michael | EVP & President, Life Sciences | Sell | 58 | $181.03 | $10,499.74 | -0.7% | → |
| 2025-09-10 | Fraser Claire | Director | Sell | 917 | $187.50 | $171,937.50 | -4.0% | → |
| 2025-08-22 | Feld Michael | EVP & President, Life Sciences | Sell | 57 | $197.99 | $11,285.43 | -0.7% | → |
| 2025-08-11 | HAYES GREGORY | Director | Buy | 5,250 | $191.57 | $1,005,742.50 | +659.5% | → |
| 2025-08-08 | Fraser Claire | Director | Sell | 863 | $192.30 | $165,954.90 | -3.6% | → |
| 2025-07-18 | Garrison Michael David | EVP & President, Medical | Sale+OE | 1,185 | $180.29 | $213,644.86 | -10.8% | → |
| 2025-06-02 | Shan David | EVP and Chief ISC Officer | Sell | 1,166 | $171.19 | $199,607.54 | -20.3% | → |
| 2025-04-09 | Garrison Michael David | EVP & President, Medical | Sell | 479 | $197.28 | $94,497.12 | -8.9% | → |
| 2025-03-18 | Byrd Richard | EVP & President Interventional | Sell | 459 | $230.00 | $105,570.00 | -6.2% | → |
| 2025-03-12 | Byrd Richard | EVP & President Interventional | Sell | 1,940 | $224.91 | $436,325.40 | -20.7% | → |
| 2025-02-12 | SCOTT BERTRAM L | Director | Sell | 700 | $227.99 | $159,593.00 | -1.9% | → |
| 2025-02-10 | Henderson Jeffrey William | Director | Buy | 1,500 | $233.62 | $350,430.00 | +23.0% | → |
| 2025-01-21 | Neal Shana Carol | EVP and Chief People Officer | Sell | 787 | $240.00 | $188,880.00 | -4.9% | → |
| 2025-01-21 | Shan David | EVP and Chief ISC Officer | Sell | 500 | $240.00 | $120,000.00 | -8.0% | → |
| 2025-01-17 | Garrison Michael David | EVP & President, Medical | Sell | 597 | $236.51 | $141,196.47 | -9.7% | → |
| 2025-01-07 | Neal Shana Carol | EVP and Chief People Officer | Sale+OE | 788 | $235.00 | $185,180.00 | -4.6% | → |
| 2024-12-19 | Garrison Michael David | EVP & President, Medical | Sell | 2,838 | $223.33 | $633,810.54 | -31.6% | → |
| 2024-12-09 | Goette Roland | EVP and President, EMEA | Sale+OE | 5,121 | $220.76 | $1,130,528.97 | -11.7% | → |
| 2024-12-06 | Neal Shana Carol | EVP and Chief People Officer | Sell | 1,000 | $220.49 | $220,490.00 | -5.6% | → |
| 2024-12-05 | Shan David | EVP and Chief ISC Officer | Sell | 1,500 | $220.25 | $330,375.00 | -19.3% | → |
| 2024-06-10 | Spoerel Thomas J | SVP,Controller&Chief Acct Off | Sell | 300 | $239.31 | $71,793.00 | -13.2% | → |
| 2024-05-15 | Goette Roland | EVP and President EMEA | Sell | 3,300 | $236.73 | $781,224.00 | -8.1% | → |
| 2024-05-13 | Goette Roland | EVP and President EMEA | Sell | 3,300 | $236.70 | $781,121.28 | -6.8% | → |
| 2024-04-30 | Garrison Michael David | EVP & President Medical | Sell | 1,715 | $232.81 | $399,269.15 | -24.2% | → |
| 2024-03-14 | Spoerel Thomas J | SVP,Controller&Chief Acct Off | Sell | 282 | $238.29 | $67,197.78 | -11.0% | → |
| 2023-12-11 | Garrison Michael David | EVP & President Medical | Sell | 1,239 | $232.46 | $288,017.94 | -14.6% | → |
| 2023-11-28 | Byrd Richard | EVP & President Interventional | Sell | 2,156 | $238.47 | $514,141.32 | -34.4% | → |
| 2023-09-05 | Byrd Richard | EVP & President Interventional | Sell | 459 | $274.48 | $125,986.32 | -11.8% | → |
| 2023-08-28 | Fraser Claire | Director | Sell | 848 | $281.66 | $238,847.68 | -3.8% | → |
| 2023-08-11 | Hickey David | EVP & President, Life Sciences | Sale+OE | 2,974 | $277.85 | $826,325.90 | -41.5% | → |
| 2023-08-08 | Garrison Michael David | EVP & President Medical | Sell | 1,300 | $277.13 | $360,269.00 | -20.1% | → |
| 2023-02-03 | Byrd Richard | EVP & President Interventional | Sell | 1,421 | $248.60 | $353,260.60 | -25.6% | → |
| 2022-08-15 | Polen Thomas E Jr | Chairman, CEO and President | Sale+OE | 9,500 | $265.13 | $2,518,735.00 | -24.8% | → |
| 2022-08-15 | Hickey David | EVP & President, Life Sciences | Sell | 475 | $265.00 | $125,875.00 | -12.5% | → |
| 2022-08-09 | Polen Thomas E Jr | Executive Vice President | Sale+OE | 1,652 | $260.00 | $429,520.00 | -5.4% | → |
| 2022-08-09 | Khichi Samrat S. | EVP and General Counsel | Sale+OE | 16,480 | $260.44 | $4,292,051.20 | -58.2% | → |
| 2022-06-07 | Spoerel Thomas J | VP Controller & Chief Acct Off | Sale+OE | 443 | $260.00 | $115,180.00 | -29.5% | → |